Respirology

Christian R Osadnik
10.1111/resp.13247

Ralf Eberhardt
10.1111/resp.13217

Athol U Wells and Katerina M Antoniou
10.1111/resp.13182

Michael W Y Tan, Sanjeev Chunilal and Darren Mansfield
10.1111/resp.13257

Grant Waterer
10.1111/resp.13238

Marcos I Restrepo and Luis F Reyes
10.1111/resp.13233

Vanessa M McDonald, Steven Maltby and Peter G Gibson
10.1111/resp.13249

Gregory G King, Alan James, Louise Harkness and Peter A B Wark
10.1111/resp.13251

Francesca Wuytack, Declan Devane, Elizabeth Stovold, Melissa McDonnell, Michelle Casey, Timothy J McDonnell, Paddy Gillespie, Adam Raymakers, Yves Lacasse and Bernard McCarthy
10.1111/resp.13224

Sarah Todd, Emil S Walsted, Lizzie Grillo, Rebecca Livingston, Andrew Menzies-Gow and James H Hull
10.1111/resp.13173

Breathing pattern disorder (BPD) can coexist with and mimic asthma, amplifying symptoms, leading to inappropriate treatment escalation. This study reveals that BPD is highly prevalent in treatment-refractory asthma and can be characterized using a breathing pattern assessment tool (BPAT). The BPAT is easy to complete and promotes physiotherapy intervention.

Andreas S Lappas, Anna S Tzortzi, Efstathia M Konstantinidi, Stephanie I Teloniatis, Chara K Tzavara, Sofia A Gennimata, Nikolaos G Koulouris and Panagiotis K Behrakis
10.1111/resp.13180

E-cigarette smoking (ECS) has immediate mechanical and inflammatory consequences in smokers, with more prominent duration and intensity in mild asthma (MA). ECS and MA also had synergistic effects on respiratory function. These findings have implications for asthma management and tobacco control.

Dalia Fakih, Zeina Akiki, Kirsten Junker, Myrna Medlej-Hashim, Mirna Waked, Pascale Salameh, Uffe Holmskov, Hasnaa Bouharoun-Tayoun, Soulaima Chamat, Grith L Sorensen and Rania Jounblat
10.1111/resp.13193

We demonstrated for the first time in a Lebanese population cohort that non-multimerized species of serum surfactant protein D (SP-D) were dominant in Met11/Met11 COPD and asthmatic patients suggesting that degradation of SP-D takes place to a significant degree in pulmonary diseases.

Jorrit B A Welling, Jorine E Hartman, Eva M van Rikxoort, Nick H T Ten Hacken, Huib A M Kerstjens, Karin Klooster and Dirk-Jan Slebos
10.1111/resp.13178

The minimal important difference (MID) for target lobar volume reduction after endobronchial valve treatment for emphysema is -563 mL. This MID can be useful for both interpreting the results from trials and clinical practice, as well as for designing future studies on lung volume reduction.

Ivo A Wiertz, Wim A Wuyts, Coline H M van Moorsel, Adriane D M Vorselaars, Hendrik W van Es, Matthijs F M van Oosterhout and Jan C Grutters
10.1111/resp.13230

Evidence is lacking to guide treatment of patients with suspected idiopathic pulmonary fibrosis (IPF) who have radiological inconsistent usual interstitial pneumonia (UIP) and UIP pattern in surgical lung biopsy. In this retrospective cohort, these patients demonstrated an accelerated decline in forced vital capacity (FVC) and multiple serious adverse events when treated with prednisone.

Masahiro Uehara, Noriyuki Enomoto, Yoshiyuki Oyama, Yuzo Suzuki, Masato Kono, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura and Takafumi Suda
10.1111/resp.13145

Patients with interstitial pneumonia (IP) and adverse effects received a significantly higher dose of pirfenidone adjusted by body surface area and body weight. In a subgroup of patients with idiopathic pulmonary fibrosis (IPF), a high/medium dose was associated with a lower decline in % forced vital capacity (FVC). Body size-adjusted dosing may be beneficial for the treatment of IP.

Man P Chung, Bo D Nam, Kyung S Lee, Joungho Han, Jai S Park, Jung H Hwang, Min J Cha and Tae J Kim
10.1111/resp.13188

In patients with cryptogenic organizing pneumonia, 77% had residual computed tomography (CT) abnormalities on follow-up CT chest, even after corticosteroid treatment. The extent of lung abnormalities, consolidation on CT, diffusion measurements and treatment duration were factors associated with residual CT abnormalities.

Taro Koba, Toru Arai, Masanori Kitaichi, Takahiko Kasai, Masaki Hirose, Kazunobu Tachibana, Chikatoshi Sugimoto, Masanori Akira, Seiji Hayashi and Yoshikazu Inoue
10.1111/resp.13190

The diagnosis yield for lymphangioleiomyomatosis by transbronchial lung biopsy (TBLB) was 70.8%. The yield of TBLB was higher in patients with a reduced diffusing capacity, suggesting that an adequate disease burden is required for this approach. The procedure seems safe, as no serious adverse events such as pneumothorax or excessive bleeding were observed.

John Kolbe
10.1111/resp.13260

R Reid Harvey, Brie M Hawley, M Abbas Virji and Kristin J Cummings
10.1111/resp.13236

Francesco Bonella, Ulrich Costabel and on behalf of all co-authors
10.1111/resp.13237